Onterris: Recurring Environmental Demand Meets One Bad Quarter and a Heavy Balance Sheet

The Quarter in Context

For the three months ended June 30, 2026, Onterris, Inc. (formerly Montrose Environmental Group) reported revenue of $186.7 million, down from $234.5 million in the second quarter of 2025. Operating income of $6.5 million compared with $14.9 million a year earlier. Net income was $1.4 million versus $18.4 million, though the prior-year figure was inflated by a $10.0 million fair-value gain tied to the now-redeemed Series A-2 preferred-stock conversion option. Diluted EPS of $0.04 trailed $0.42 a year ago.

The real story is the segment mix. Consulting and Treatment revenue fell 26.9% year over year, almost entirely because environmental-emergency-response revenue collapsed from $48.5 million to $10.8 million — the prior-year quarter included roughly $53.6 million from a single response event that did not recur. Core consulting revenue actually grew, and Consulting and Treatment Adjusted EBITDA margin expanded to 22.2% from 21.9% on better project mix and the exit of the loss-making renewables business. Measurement and Analysis revenue slipped 2.8% and its margin compressed to 26.2% from 29.1%. On a six-month basis, operating cash flow flipped to a $5.5 million use from a $27.4 million source a year ago, driven by lower earnings and a $27.7 million bonus payout. This is a single quarter, but it tells us whether the earning engine still runs when the episodic fuel is removed — and the answer is yes, at lower volumes.

Business Model and Profit Engine

Onterris describes itself as an environmental services company serving recurring, often non-discretionary regulatory needs of a diverse client base, including Fortune 500 companies and federal, state and local governments. After a Q1 2026 segment realignment, the company operates two reportable segments plus a corporate line: Consulting and Treatment (environmental consulting, engineering, permitting, emergency response, water-treatment design and operation, soil remediation) and Measurement and Analysis (emissions sampling, ambient-air monitoring, leak detection, multi-media laboratory services). The company does not own the underlying environmental liabilities it manages; it sells expertise, capacity and laboratory throughput.

Revenue is generated from contracts that are predominantly fixed-fee or time-and-materials, billed periodically as work progresses. Customers are diversified — no customer accounted for more than 10% of revenue in either the three- or six-month 2026 periods. Revenue becomes gross profit through cost of revenues (essentially direct labor, subcontractors and lab consumables), then operating profit after SG&A and depreciation. Segment Adjusted EBITDA for Q2 was $43.9 million at a 23.5% margin versus $55.9 million at 23.8% a year ago. SG&A as a percentage of revenue rose to 35.0% from 33.9% because the revenue base shrank, not because the cost base expanded.

Who pays, then, is a mix of private industrial firms with regulated environmental footprints and public-sector clients whose compliance spending is budgeted. The economic engine is utilization of credentialed scientists, lab capacity and field crews, billed against multi-year recurring needs. Pricing power is asserted on short- and medium-term contracts as they renew, with management claiming it has offset modestly higher labor costs through price increases. Operating leverage is real but lumpy: when emergency-response volumes vanish, SG&A does not flex proportionally. Working capital is the swing factor for cash — accounts receivable dropped $15 million in the first half on improved collections, but accrued payroll fell $22 million after the bonus payout. Reinvestment is moderate: $11.3 million of property and equipment purchases in H1 2026 versus $5.1 million a year ago. The filings do not separate maintenance from growth capex, so we cannot quantify how much is keeping the labs running versus expansion.

Observable conditions that would weaken this profit engine include a sustained decline in core consulting demand, continued margin compression in Measurement and Analysis, or a regulatory pullback that reduces recurring testing volumes. We lack filed evidence on backlog by segment beyond the $49.9 million of remaining unsatisfied performance obligations as of June 30, 2026, which is not enough to size the forward book.

Earnings Quality and Cash Conversion

Where the issuer reports cash flow and capital expenditure cumulatively, the standalone-quarter cash-flow figures are derived by subtracting the preceding cumulative filing. They are calculations from SEC facts rather than separately reported quarterly line items.

Earnings quality is mixed and is the central problem with this story. On a trailing-twelve-month basis, revenue is $773.3 million, operating income is $7.75 million and net income is negative $11.2 million, but free cash flow is a positive $52.1 million. The split between a loss-making income statement and positive cash generation is explained by working-capital releases and high non-cash depreciation and stock-based compensation — not an indication of high-quality recurring profit. For the most recent quarter alone, operating cash flow of $6.2 million was a derived figure calculated from the six-month cumulative filing minus Q1, and capital expenditure of $5.7 million (also derived) yields a roughly $0.5 million accounting free-cash-flow proxy for the quarter. We label this an accounting free-cash-flow proxy rather than "Buffett owner earnings" because the filings do not separate maintenance from growth capex.

Stock-based compensation is large and persistent: $9.6 million in Q2 2026, $18.7 million for the six months, and $36.9 million on a trailing-twelve-month basis. Adding it back as if it were a non-cash item is mechanical, but at this scale it represents roughly 4.8% of trailing revenue and is a real economic cost of paying employees and directors with diluted equity. Goodwill of $465.8 million plus $113.6 million of intangibles against stockholders' equity of $430.3 million is a heavy intangible load — tangible book value is negative $149 million. The Q1 2026 loss included a recovery of credit losses of $1.4 million, and prior periods included fair-value gains on the preferred conversion option that flattered net income. Adjusting for these non-recurring items is reasonable, but the income statement does not normalize cleanly into a steady-state earnings number.

In short, reported earnings look better than the trend of operations, and reported cash flow looks better than the trend of profitability. Until the company can deliver positive six-month operating cash flow without working-capital releases, we treat cash conversion as a watch item, not a strength.

Business Quality, Moat, and Industry Position

The qualitative moat story is built on three filings-supported pillars: a fragmented industry where the U.S. environmental-services market totals roughly $620 billion in 2026 and is growing at about 4% annually; regulatory-driven, non-discretionary demand for environmental testing, permitting and remediation; and the scale advantages of a multi-office platform with roughly 120 offices and 3,500 employees across the United States, Canada and Australia. The 10-K argues that the technical expertise, accreditations and licenses required across multiple jurisdictions create barriers to entry. Approximately 96% of fiscal-2024 revenue came from clients who repeated in fiscal 2025, which is a meaningful retention data point.

The industry structure, however, is explicitly fragmented with "no single market leader" and "thousands of firms" operating in the company's markets. Onterris is therefore an important participant rather than a bottleneck-tier consolidator: it has scale, but it competes in many local markets against smaller specialists. The supply chain role is a service-provider role — between regulated end customers (industrial firms, governments) and a workforce of credentialed scientists and field crews. Substitutability is moderate; switching costs for compliance-driven testing are real but not extreme, and emergency-response work is procured episodically. Capacity elasticity is high in the medium term because the business is people-and-lab-heavy. The filings do not give us supplier concentration, qualified-bidder data or any externally verifiable customer win/loss information; we therefore treat the moat as a hypothesis supported by retention data and industry structure, not a demonstrated economic rent.

Observable conditions that would weaken this moat include industry consolidation that lets a larger competitor outbid for talent and accreditations, or regulatory simplification that reduces recurring testing demand. The company also faces a real concentration risk in episodic revenue: a single response event generated $53.6 million in the prior-year period, illustrating how lumpy the top line can be.

Management and Capital Allocation

Capital allocation over the past year shows a clear pivot from acquisition-heavy growth toward debt reduction and shareholder returns. In April and July 2025, Onterris redeemed the remaining $122.2 million of Series A-2 preferred stock, ending a costly dividend obligation. In May 2025, the board authorized a $40 million share-repurchase program; through Q2 2026, the company has repurchased 1,627,763 shares for roughly $30.0 million, with about $10.0 million of capacity remaining. Average repurchase prices of $15.76 in May and $16.49 in June sit below the prior 10-K disclosure of $25.43 weighted-average exercise price on outstanding stock options, suggesting management is buying back stock below the strike of outstanding options — a defensible discipline.

Total debt rose to $349.0 million from $277.1 million (long-term portion) at year-end 2025, primarily through the 2025 Credit Facility, with $148.1 million of remaining availability and $12.7 million of cash on hand. Net debt is therefore $336.3 million, against a dated market capitalization of $561.9 million — leverage is meaningful but not extreme. Interest expense, net, rose to $5.5 million in Q2 from $4.8 million a year ago on higher debt balances. Interest-rate exposure on unhedged variable-rate debt is roughly $2.0 million of annual pre-tax sensitivity per 100 basis points, partially offset by interest-rate swaps on $155.0 million of debt. The Q1 2026 realignment of segments and the April 2026 rebrand from Montrose to Onterris are administrative actions, not capital-allocation moves. The pattern — preferred redemption, then buybacks, with revolver-driven working capital and acquisitions — is consistent with management prioritizing per-share value over empire-building, though the negative six-month operating cash flow means buybacks in 2026 are being funded in part by the credit line rather than internally generated cash.

Valuation and What the Market Already Expects

The dated market snapshot shows Onterris at $16.00 per share with a market capitalization of $561.9 million, as of August 26, 2026. Shares outstanding as of July 31, 2026 were 35,117,424. The company's own filings report 36,737,899 issued shares and 35,110,136 outstanding shares at June 30, 2026, after treasury-stock repurchases. Net debt at quarter-end was $336.3 million, so enterprise value is roughly $898 million at the dated price.

Against trailing-twelve-month revenue of $773.3 million and operating income of $7.8 million, the market is paying roughly 1.2x sales and a very large multiple of operating income — the latter simply reflects that trailing operating income is depressed by working-capital noise and a weak first half. The more meaningful lens is cash. Trailing-twelve-month free cash flow of $52.1 million against an $898 million enterprise value implies an unlevered free-cash-flow yield around 5.8% — not demanding for an environmental-services platform with regulatory tailwinds, but not cheap either. We do not label a price-to-earnings ratio on this quarter alone because the prior-year EPS base was distorted by the preferred-conversion fair-value gain. Year-to-date revenue is down 20.4%, so the dated market capitalization is implicitly asking the operating engine to stabilize — not grow — and for cash conversion to recover into the second half. Whether the dated price already discounts this stabilization is the question the valuation analysis section below addresses qualitatively.

Ten-Year Cash Flow to Fair Market Value

The starting free cash flow is the normalized SEC cash-flow proxy, while every growth rate, discount rate and terminal rate below is an explicit editorial assumption rather than company guidance. Each annual cash flow is forecast and discounted separately; terminal value is year-ten free cash flow multiplied by one plus terminal growth, divided by discount rate minus terminal growth, and then discounted back ten years. Fair market capitalization equals that explicit ten-year present value plus discounted terminal value and a same-date balance-sheet adjustment when available. If current cash and debt facts do not share one report date, the table shows the adjustment as unavailable and conservatively applies zero. The share count is derived from the dated market capitalization and share price so US shares and foreign ADRs use a consistent traded-security denominator.

In the reverse-DCF, holding the 9% discount rate and 3% terminal growth fixed, and solving only for one constant growth rate rather than using the base-case growth path, the current market capitalization implies roughly 3.1% annual free cash flow growth for ten years. This is a sensitivity framework, not a price target: the terminal-value share shows how strongly each result depends on assumptions beyond the explicit forecast. Negative margin of safety means the current market capitalization exceeds the scenario value.

Five Value-Investing Lenses

Benjamin Graham Lens

The Graham test starts with balance-sheet resilience. Goodwill of $465.8 million and intangibles of $113.6 million swamp stockholders' equity of $430.3 million, producing negative tangible book value of roughly $149 million. Current assets of $238.3 million versus current liabilities of $119.3 million give a 2.0x current ratio, which is healthy, but the long-term debt load of $337.8 million is large relative to a trailing-twelve-month operating cash flow swing that turned negative in the first half of 2026. A market price near book value per share plus net debt would be a defensible Graham anchor, and at $16 the shares trade at a meaningful premium to that anchor. Six months of negative operating cash flow, episodic-revenue collapse and stock-based compensation near 5% of revenue argue against declaring the equity statistically cheap. The dated price does not yet provide a clear margin of safety on this evidence.

Benjamin Franklin Lens

The Franklin lens is about capital discipline and opportunity cost. Management has done three things well in 2025-2026: redeemed the $122.2 million preferred stock that was eating cash through dividends and dilution, repurchased stock at prices below the weighted-average option strike of $25.43, and consolidated three legacy segments into two. Those are disciplined choices. On the other side, the company funded $30.0 million of buybacks in the first half while reporting $5.5 million of operating-cash outflow; the buyback arithmetic only makes sense if the equity is genuinely undervalued, and we have not been given enough evidence to confirm that. Interest expense rising 11.2% on higher debt balances is the opportunity-cost flip side: every margin point on the credit facility is cash that cannot fund buybacks or reduce leverage further. Discipline is improving, but the balance sheet is not yet thrifty in the Franklin sense.

Warren Buffett Lens

Buffett's owner-earnings question is whether normalized cash earnings justify the enterprise value. We cannot construct a true owner-earnings figure because the filings do not separate maintenance from growth capex; operating cash flow minus total capex of $22.5 million on a trailing basis is the accounting proxy. Adding back stock-based compensation of $36.9 million is mechanical but partial. Against a roughly $898 million enterprise value, an accounting proxy near $75 million of cash earnings supports a yield in the high single digits, which is interesting but not exceptional for a fragmented, project-driven services business. The intangible load is the Buffett worry: two-thirds of total assets are goodwill and intangibles, which means a lot of the enterprise value depends on continued execution. Capital allocation has improved but buybacks ahead of an improving balance sheet is a question of sequencing, not conviction.

Charlie Munger Lens

Inversion asks: how does this become a permanent loss? The most plausible path is a multi-quarter decline in environmental-emergency-response revenue combined with continued margin compression in Measurement and Analysis, leaving the company unable to service its revolver while goodwill stays on the books. A second path is regulatory simplification that reduces recurring testing volumes — explicitly listed as a risk factor in the 10-K. The most likely wrong assumption is that the prior-year $53.6 million response event was a recurring base; treating it as such overstates the run-rate. Incentive alignment looks reasonable: officers and directors own equity, compensation is disclosed, and the redemption of the dilutive preferred removed a layer of misalignment. The bias to watch is the temptation to call a 96% client-retention number a moat when retention of a fragmented, low-switching-cost base is table stakes in the industry.

Li Lu Lens

Li Lu would start with circle of competence. Environmental services is a regulated, recurring-revenue industry with high revenue visibility from compliance work but low barriers to entry at the local level — comfortable ground for an analytical investor, but not an obvious circle-of-competence standout. Durability depends on continued regulation and continued fragmentation; if either reverses, the platform economics weaken. Culture evidence is mostly neutral: clean auditor opinion (Deloitte & Touche LLP per the 10-K exhibit list ), no material weaknesses disclosed, effective disclosure controls, and a recently announced rebrand to Onterris that does not affect operations. We lack third-party customer or supplier testimony, and we lack any external verification of management's growth or margin claims. Permanent-loss control rests on whether management continues to reduce leverage and avoid large acquisitions while the recurring base stabilizes. We are inside the circle of competence, but the evidence is thin enough to keep confidence below average.

Risks, Disconfirming Evidence, and What Would Prove This Thesis Wrong

Three observable thesis breakers would force a conclusion change. First, a second consecutive quarter of negative or near-zero operating cash flow would signal that the negative H1 2026 reading was not a working-capital timing issue but a structural deterioration. Second, a further compression of Measurement and Analysis Adjusted EBITDA margin below the 22.5% six-month level, which would indicate that the recurring testing business is losing pricing power. Third, any goodwill impairment charge in a future filing, which would confirm that the $465.8 million book value of goodwill overstates the platform's earning power relative to what the market currently pays. Disconfirming evidence already in hand includes the 20.4% year-over-year revenue decline, the six-month operating cash outflow, and the prior-period reliance on a single $53.6 million emergency-response event. The most likely wrong assumption is that the recurring core will recover to 2025 run-rate volumes in the second half; the dated market capitalization does not require this, but it does require cash conversion to normalize.

Investment Conclusion

Across the five lenses, Onterris shows up as an environmental-services platform with regulated recurring demand, fragmented-industry scale advantages, and improving but incomplete capital discipline, sitting on a balance sheet whose intangibles and leverage leave little margin of safety at the dated $16 price. The deterministic ten-year valuation places the dated market capitalization near the base scenario, so the qualitative implication is fairly valued rather than attractive or expensive. Six months of negative operating cash flow, persistent goodwill concentration and stock-based compensation near 5% of revenue prevent us from declaring the equity undervalued. We rate Onterris as fairly valued and avoid initiating a position pending better evidence on cash conversion, Measurement and Analysis margin stability and a clean quarter of positive operating cash flow.

*This article is for educational and informational purposes only and is not investment advice. It reflects analysis of public SEC filings and a dated market snapshot; it does not constitute a recommendation to buy, sell or hold any security. Past performance does not guarantee future results.*